Health
Qilu Pharmaceutical Releases Latest Results of QL1604 plus Chemotherapy as First-Line Treatment for Patients with Advanced Cervical Cancer in the Phase II Study at ESMO Asia Congress 2022
JINAN, China, Dec. 4, 2022 /PRNewswire/ -- Qilu Pharmaceutical, one of the leading vertically integrated pharmaceutical companies inChina that develops, manufactures, and distributes both finished formulations and Active Pharmaceutical Ingredients, announced that the results of the phase II study...
2022-12-04 17:00
1619
JelloX Biotech Leads Research in 3D Cancer Pathology as NCI Explores Potential
SAN FRANCISCO, Dec. 2, 2022 /PRNewswire/ -- JelloX Biotech is celebrating a robust year of research and product development milestones while showcasing the potential for 3D imaging and AI to be the future of cancer pathology. Presently, most cancer diagnosis is done through thinly sliced physic...
2022-12-03 09:58
2482
China Pharma Announces Receipt of Noncompliance Notice from NYSE American
HAIKOU, China, Dec. 2, 2022 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma," the "Company" or "We"), a specialty pharmaceutical company, today announced that onDecember 1, 2022, received a notification (the "Deficiency Letter") from the NYSE American LLC (the "NY...
2022-12-03 05:10
3616
Lakeshore Acquisition Corp I Shareholders Approve Business Combination with ProSomnus
SAN FRANCISCO, Dec. 2, 2022 /PRNewswire/ -- Lakeshore Acquisition I Corp. (Nasdaq: LAAA) ("Lakeshore") today announced that its shareholders have approved all proposals related to the previously announced business combination (the "Business Combination") with ProSomnus Holdings, Inc. ("ProSomnus"...
2022-12-03 05:05
4024
Qilu Pharmaceutical Releases Latest Results of QL1706 plus Chemotherapy +/- Bevacizumab for the Treatment of Non-Small Cell Lung Cancer in the Phase II Study at ESMO Asia Congress 2022
JINAN, China, Dec. 2, 2022 /PRNewswire/ -- Qilu Pharmaceutical, one of the leading vertically integrated pharmaceutical companies inChina that develops, manufactures, and distributes both finished formulations and Active Pharmaceutical Ingredients, announced that the results of the phase II study...
2022-12-02 16:20
1462
Waterdrop Inc. to Report Third Quarter 2022 Financial Results on December 6, 2022
BEIJING, Dec. 1, 2022 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it will report its unaudited financial results for the third quarter end...
2022-12-02 11:43
3029
Jacobio's Preclinical Results of KRAS G12C Inhibitor in Combination with SHP2 Inhibitor Will be Presented at the ESMO Asia Congress 2022
BEIJING, SHANGHAI and BOSTON, Dec. 1, 2022 /PRNewswire/ -- Jacobio Pharma (1167.HK) will present the results of KRAS G12C inhibitor JAB-21822 as a single agent or in combination withSHP2 inhibitor JAB-3312 in preclinical cancer models in a poster session during the 2022 European Society of Medica...
2022-12-02 08:30
1505
Kintor Pharma Announced the Primary Endpoint of Phase II Clinical Study for KX-826's Treatment of Female Androgenetic Alopecia in China Was Met
SUZHOU, China, Dec. 1, 2022 /PRNewswire/ -- Kintor Pharmaceutical Limited ("KintorPharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecules and biological therapeutics, today announced results of phase II clinical trial of pyrilutamide (KX-826), a poten...
2022-12-01 19:30
1563
111, Inc. Announces Third Quarter 2022 Unaudited Financial Results
SHANGHAI, Dec. 1, 2022 /PRNewswire/ – 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to digitally connecting patients with medicine and healthcare services inChina, today announced its unaudited financial results for the third quarter...
2022-12-01 15:33
2565
SK Biopharmaceuticals Names Donghoon Lee, Head of Bio Investment Center of SK Inc., as New CEO
Mr. Lee brings expertise in global new biz development to further strengthen SK Biopharmaceuticals as SK Group's key bio business PANGYO, South Korea, Nov. 30, 2022 /PRNewswire/ -- SK Biopharmaceuticals, an innovative global pharmaceutical company, announced that it has named Mr. Donghoon Lee, Ex...
2022-12-01 09:30
1901
New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio
DUBLIN, Dec. 1, 2022 /PRNewswire/ -- ERS Genomics Limited ('ERS') is pleased to
announce a new license agreement withCosmo Bio. This is a non-exclusive license
agreement grantingJapan's Cosmo Bio access to the ERS CRISPR/Cas9 patent
portfolio.
2022-12-01 08:00
1388
TIANGEN to Roll out a Stunning Automated Solution at Cell Bio 2022
WASHINGTON, Nov. 30, 2022 /PRNewswire/ -- TIANGEN, a leading brand in the field of nucleic acid purification inChina, has announced its participation in the Cell Bio 2022, the joint meeting of the American Society for Cell Biology (ASCB) and European Molecular Biology Organization (EMBO), fromDec...
2022-11-30 21:20
1566
Ascletis Announces Completion of 180 Patient Enrollment for Phase II Clinical Trial of FASN Inhibitor ASC40 for Acne
--To date, approximately 50% enrolled patients have completed 12-week treatment and all enrolled patients are expected to complete 12-week treatment by the end ofFebruary 2023 -- Clinical efficacy observed in patients who have completed 12-week treatment of ASC40 or placebo was comparable t...
2022-11-30 20:39
1463
Navigating a perfect storm - driving access to healthcare in emerging markets
* Healthcare demand and expenditure in Southeast Asia are set to increase rapidly amidst rising affluence and an ageing population * Emerging markets comprise 60% of the global population but contribute only 20% of global healthcare spending, highlighting the issue of equitable access * An i...
2022-11-30 15:00
1620
WuXi AppTec Receives 2022 Global Contract Research, Development and Manufacturing Organization Company of the Year Award from Frost & Sullivan
SHANGHAI, Nov. 29, 2022 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services for the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients, announced that it is a r...
2022-11-30 08:00
2309
COSMAX Group Expands Business to Pet Care...Targeting $200B Market
* Started operations of pet supplements manufacturing plant * Produces 'human-grade' products with differentiated ingredients * Plans to expand pet care business from supplements to cosmetics SEONGNAM, South Korea, Nov. 29, 2022 /PRNewswire/ -- COSMAX Group, the leader in the global cosmetic...
2022-11-29 22:00
3117
United Imaging Selected to Academy of Radiology & Biomedical Imaging Research's Council of Distinguished Investigators' Class of 2022
United Imaging's Chief Technology Officer recognized at a ceremony and reception during RSNA onTuesday, November 29, 2022. HOUSTON, Nov. 29, 2022 /PRNewswire/ -- United Imaging, a global leader in producing advanced medical imaging and radiotherapy equipment, is welcomed today to the Distinguis...
2022-11-29 22:00
2986
Mintal Tracker Wins Highest Honor From Prestigious 2022 Fall Digital Health Awards
The award-winning app uses AI to monitor and help users achieve healthier sleep
SUNNYVALE, Calif., Nov. 29, 2022 /PRNewswire/ -- Mintal Tracker, a sleep
tracking app driven by artificial intelligence (AI) technology that offers a
scientific approach to healthier sleep,received
2022-11-29 21:00
2113
Yuyu Pharma Plans to Enter the U.S. and European Markets for Hair Loss Treatment
SEOUL, South Korea, Nov. 29, 2022 /PRNewswire/ -- At the World Congress for
Hair Research 2022 (Melbourne, Australia), Yuyu Pharma shared its plans to
conduct clinical trials in the U.S. andEurope for its Dutasteride Tablet
("DUT") for the treatment of Androgenetic Alopecia ("AGA").
2022-11-29 16:20
2667
AROA BIOSURGERY ANNOUNCES HALF YEAR RESULTS
AUCKLAND, New Zealand, Nov. 29, 2022 /PRNewswire/ -- Today New Zealand based soft-tissue regeneration company Aroa Biosurgery (AROA, the Company) is pleased to announce financial results for H1 FY23. With fewer COVID-19 related disruptions, the Company has entered FY23 with momentum and delivere...
2022-11-29 13:24
2302
Week's Top Stories
Most Reposted
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
[Picked up by 319 media titles]
2024-11-07 09:00
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 311 media titles]
2024-11-12 09:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 288 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 285 media titles]
2024-11-12 11:00
Most Read
Mastercard goes OTP-free in APAC for faster, safer online transactions
2024-11-06 09:00
13462
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
2024-11-07 09:00
10126
XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific
2024-11-07 11:34
7487
XTEP's First Mono Store in Malaysia Comes to Puchong
2024-11-07 10:08
6205
